Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes
Gillian L Dalgliesh1, Kyle Furge, Chris Greenman
1Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, UK.
Abstract:
Clear cell renal cell carcinoma (ccRCC) is the most common form of adult kidney cancer, characterized by the presence of inactivating mutations in the VHL gene in most cases, and by infrequent somatic mutations in known cancer genes. To determine further the genetics of ccRCC, we have sequenced 101 cases through 3,544 protein-coding genes. Here we report the identification of inactivating mutations in two genes encoding enzymes involved in histone modification-SETD2, a histone H3 lysine 36 methyltransferase, and JARID1C (also known as KDM5C), a histone H3 lysine 4 demethylase-as well as mutations in the histone H3 lysine 27 demethylase, UTX (KMD6A), that we recently reported. The results highlight the role of mutations in components of the chromatin modification machinery in human cancer. Furthermore, NF2 mutations were found in non-VHL mutated ccRCC, and several other probable cancer genes were identified. These results indicate that substantial genetic heterogeneity exists in a cancer type dominated by mutations in a single gene, and that systematic screens will be key to fully determining the somatic genetic architecture of cancer.
Insights
Researchers identified new genetic mutations in clear cell renal cell carcinoma (ccRCC), a common kidney cancer. These mutations affect genes involved in histone modification, revealing significant genetic diversity beyond VHL gene mutations.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- Clear cell renal cell carcinoma (ccRCC) is the most prevalent adult kidney cancer.
- Most ccRCC cases feature inactivating mutations in the VHL gene.
- Somatic mutations in known cancer genes are infrequent in ccRCC.
Purpose of the Study:
- To further elucidate the genetic landscape of ccRCC.
- To identify novel genes and pathways implicated in ccRCC development.
Main Methods:
- Sequencing of 101 ccRCC cases across 3,544 protein-coding genes.
- Identification and analysis of somatic mutations.
Main Results:
- Discovered inactivating mutations in SETD2 (histone H3 lysine 36 methyltransferase) and JARID1C/KDM5C (histone H3 lysine 4 demethylase).
- Confirmed mutations in UTX/KMD6A (histone H3 lysine 27 demethylase).
- Identified NF2 mutations in ccRCC cases without VHL mutations and other potential cancer genes.
Conclusions:
- Mutations in chromatin modification machinery components play a role in ccRCC pathogenesis.
- Significant genetic heterogeneity exists in ccRCC, extending beyond VHL gene mutations.
- Systematic genetic screens are crucial for a comprehensive understanding of ccRCC's somatic genetic architecture.
More Related Videos
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
Histone Modification
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone deacetylase,...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Spreading of Chromatin Modifications
Writers
The writer is an enzyme that can...


